The rise in vancomycin-resistant Enterococcus faecium in Germany: data from the German Antimicrobial Resistance Surveillance (ARS)
01 September 2019
Proportions of vancomycin resistance in clinical E. faecium isolates from German hospitals are increasing underlining the growing significance of E. faecium infections for public health. VREF proportions differ considerable among German regions with a particular focus of high vancomycin resistance in Southwest and Southeast Germany. Continued surveillance and implementation of effective infection prevention and control measures accounting for local resistance differences are needed to reduce the spread of vancomycin-resistant E. faecium in German hospitals.
Further reading: Antimicrobial Resistance & Infection Control
Author(s): Robby Markwart, Niklas Willrich, Sebastian Haller, Ines Noll, Uwe Koppe, Guido Werner, Tim Eckmanns & Annicka Reuss
Effective Surveillance
OUR UNDERWRITERS
Unrestricted financial support by:
 |
LifeArc |
 |
Antimicrobial Resistance Fighter Coalition |
 |
Bangalore Bioinnovation Centre |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
AMR NEWS
Every two weeks in your inbox
Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!